GEn 1200mg/day

DRUG3 trials

Sponsors

XenoPort, Inc.

Conditions

Neuralgia, PostherpeticNeuropathy, Diabetic

Phase 2

A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment

CompletedNCT00617461

XenoPort, Inc.Neuralgia, Postherpetic

Start: 2008-03-31End: 2009-07-31Updated: 2013-07-22

A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN)

CompletedNCT00619476

XenoPort, Inc.Neuralgia, Postherpetic

Start: 2008-02-29End: 2009-07-31Updated: 2013-07-22

A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)

CompletedNCT00643760

XenoPort, Inc.Neuropathy, Diabetic

Start: 2008-03-31End: 2009-02-28Updated: 2013-07-22

Related Papers

A phase 2a, randomized, crossover trial of gabapentin enacarbil for the treatment of postherpetic neuralgia in gabapentin inadequate responders.

2013-09-185 citations

A randomized, controlled trial of gabapentin enacarbil in subjects with neuropathic pain associated with diabetic peripheral neuropathy.

2012-11-2747 citations